India’s daily new COVID-19 cases have hovered around 10,000 for the past few weeks, taking the total to 34.67 million, more than 474,000 of whom have died.New Delhi: A 3-year-old child was among seven new patients with the Omicron variant of COVID-19 reported in Maharashtra on Friday, taking India’s tally to 32 on a day when the government warned about weakening coronavirus precautions like mask-wearing.
“Overall 25 Omicron cases have been detected in the country so far.
India’s daily new COVID-19 cases have hovered around 10,000 for the past few weeks, taking the total to 34.67 million, more than 474,000 of whom have died.New Delhi: A 3-year-old child was among seven new patients with the Omicron variant of COVID-19 reported in Maharashtra on Friday, taking India’s tally to 32 on a day when the government warned about weakening coronavirus precautions like mask-wearing.
“Overall 25 Omicron cases have been detected in the country so far.
India’s daily new COVID-19 cases have hovered around 10,000 for the past few weeks, taking the total to 34.67 million, more than 474,000 of whom have died.New Delhi: A 3-year-old child was among seven new patients with the Omicron variant of COVID-19 reported in Maharashtra on Friday, taking India’s tally to 32 on a day when the government warned about weakening coronavirus precautions like mask-wearing.
“Overall 25 Omicron cases have been detected in the country so far.
India’s daily new COVID-19 cases have hovered around 10,000 for the past few weeks, taking the total to 34.67 million, more than 474,000 of whom have died.New Delhi: A 3-year-old child was among seven new patients with the Omicron variant of COVID-19 reported in Maharashtra on Friday, taking India’s tally to 32 on a day when the government warned about weakening coronavirus precautions like mask-wearing.
“Overall 25 Omicron cases have been detected in the country so far.
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
\
\
\
\
